Navigation Links
Insulet Appoints Bill Arthur as Vice President of Business Development
Date:9/3/2008

Seasoned Industry Executive to Lead Company's Business Development

Initiatives

BEDFORD, Mass., Sept. 3 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the leader in patch pump technology with its OmniPod(R) Insulin Management System, today announced the appointment of William "Bill" D. Arthur III as Vice President of Business Development. In this role, Mr. Arthur will lead the company's business development strategy, including pursuing opportunities to expand the market for the OmniPod System in new applications and geographies.

"We are delighted to welcome Bill to the Insulet team. Bill is an expert in the infusion pump market and his experience will be a tremendous asset to the Company as we seek additional applications for the OmniPod System," said Duane DeSisto, Insulet's president and chief executive officer.

Most recently, Mr. Arthur served as President and COO of SpectRx, Inc., where he oversaw the design, contract manufacture and world-wide marketing of the company's insulin pump infusion set disposables. Previously, Mr. Arthur spent eight years at MiniMed, Inc. as Vice President of Sales and Reimbursement, where he helped drive annual sales of insulin infusion pumps from $6 million to over $294 million. Mr. Arthur was also Founder, President, and CEO of MedFusion, Inc., a developer of syringe infusion pumps. His experience also includes roles at PaceSetter Systems, Inc., Auto-Syringe, Inc. and Becton-Dickinson & Company. Mr. Arthur holds a Bachelor of Science degree in Microbiology from Pennsylvania State University.

About Insulet Corporation

Insulet Corporation is an innovative medical device company dedicated to improving the lives of people wit
'/>"/>

SOURCE Insulet Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Insulet Reports Second Quarter 2008 Results
2. Insulet Reports First Quarter 2008 Results
3. Insulet Corporation to Report Fourth Quarter and Full Year 2007 Financial Results on Monday, March 17
4. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
5. Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives
6. Micromet, Inc. Appoints Barclay Phillips as Senior Vice President and Chief Financial Officer
7. Landauer, Inc. Appoints Two New Members to Board of Directors
8. ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer
9. Regenerative Medicine Appoints Cell Therapy Group Consultant to Editorial Board
10. UltraShape Appoints Assaf Eyal as President & CEO
11. RHEI Pharmaceuticals Appoints Dr. Geert Cauwenbergh as Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Dec. 22, 2014  ( www.competitivehealth.com ) — Competitive ... medical bill review and advocacy service, has signed an ... WellCard Savings discount health services marketplace. 63% ... more than they expected to pay. As part of ... costs, WellCard Savings is pleased to offer medical bill ...
(Date:12/22/2014)... 22, 2014 Fertility Associates of Memphis ... Bank USA , a network of more than 20 ... partnership, patients have fast access to a national pool ... IVF . Fertility Associates of Memphis is the only ... treatment option. , Dr. William Kutteh , director ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one ... of Nick Maroulis, Pharm.D. to the newly created position ... In this position, Dr. Maroulis will continue to manage ... of our multi-site pharmacies as the company expands. Dr. ... that time he has served in many different capacities ...
(Date:12/19/2014)... Dec. 19, 2014 Bina Technologies, Inc. (Bina, ... that they have been acquired by Roche (SIX: RO, ... privately held company that provides a big data platform ... (NGS) data for the academic and translational research markets. ... and will continue to focus on development of their ...
Breaking Biology Technology:WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... Inc., a wholly owned,subsidiary of SBT Holdings Inc., which is ... completed the tender offer for,all of the outstanding shares of ... tender offer expired, as scheduled, at 5:00 p.m., New,York City ... the offer has advised that, as of the expiration of,the ...
... for Thursday, March 27TH AT 5 PM ... ... IMRX ) today announced that the Company will host a live,webcast and conference ... and fourth quarter 2007 financial results., The live webcast can be accessed ...
... BC, March 20 /PRNewswire-FirstCall/ - Chromos Molecular,Systems Inc. ... a secured, convertible debenture agreement to borrow $400,000. ... to fund expenses associated with the,preparation of delinquent ... remaining assets of the Company. The principal and,interest, ...
Cached Biology Technology:SBT Acquisition Inc. Successfully Completes Tender Offer for Shares of Lifecore Biomedical, Inc. 2SBT Acquisition Inc. Successfully Completes Tender Offer for Shares of Lifecore Biomedical, Inc. 3ImaRx to Report Corporate Updates and 4Q07 Financial Results 2Chromos enters into loan and lending arrangements 2
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... addition of the "Global Facial Recognition Market ... http://photos.prnewswire.com/prnh/20130307/600769 Facial ... of individuals. Facial recognition system measures the overall ... jaw edges, mouth, and the distance between eyes. ...
(Date:12/11/2014)... 10, 2014  Data Sciences International (DSI), the ... a new series of digital telemetry implants to ... M series, part of the PhysioTel™ Digital platform, ... possible physiologic data when incorporating functional endpoints into ... to toxicology studies has evolved from short ECG ...
(Date:12/10/2014)... 9, 2014 CIE San Diego has launched ... the connective tissue that enhances care coordination among social ... share client-level information; earned a second $1 million grant ... serving seniors aging in community and; will be recognized ... 11 th 4-6p. CIE San Diego ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3New telemetry implants expected to change how large animal toxicology studies are conducted 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4
... This release is available in Spanish . ... Exploration of the Sea) met in Bilbao from 5 to 11 ... Dory on the south platform. The meeting was coordinated by AZTI-Tecnalia ... it is held in Bilbao (previously it was held there in ...
... Singapore,s Agency for Science, Technology and Research (A*STAR), have made ... treatment. Their work, published online in the leading journal ... on how to tap on the properties of p53, the ... cells while sparing normal cells. The researchers, led by ...
... timing of umbilical cord clamping at birth should be delayed ... of South Florida,s Center of Excellence for Aging and Brain ... longer period of time allows more umbilical cord blood volume ... period extended, many good physiological "gifts" are transferred through ,nature,s ...
Cached Biology News:Meeting of ICES/CIEM experts in Bilbao on state of demersal fish populations 2Singapore scientists exploit knowledge of p53 for increasing specificity of cancer treatments 2Do we clamp the umbilical cord too soon? 2Do we clamp the umbilical cord too soon? 3
Request Info...
...
... potent inhibition of RNase A-type ribonucleases Product ... of nonhuman origin that binds noncovalently and ... A, B, and C). It does not ... U2, or CL3. QIAGEN RNase Inhibitor inhibits ...
Request Info...
Biology Products: